Evidence map›Paper›PMID 26780348›Full record

ArticlePharmacology, biochemistry, and behavior2017

Sex differences in the subjective effects of oral Δ

Jessica S Fogel, Thomas H Kelly, Philip M Westgate, Joshua A Lile

Abstract readControlled Clinical Trial
In one paragraph

Article in Pharmacology, biochemistry, and behavior, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 61 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
61citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

61 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Sex- and Gender-Based Analysis in Cannabis Treatment Outcomes: A Systematic Review.International journal of environmental research and public health · 2020
    Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article

1 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Jessica S FogelDepartment of Psychology, University of Kentucky College of Arts and Sciences, 106-B Kastle Hall, Lexington, KY 40506-0044, United States.
Thomas H KellyDepartment of Behavioral Science, University of Kentucky College of Medicine, College of Medicine Office Building, Lexington, KY 40536-0086, United States; Department of Psychology, University of Kentucky College of Arts and Sciences, 106-B Kastle Hall, Lexington, KY 40506-0044, United States; Department of Psychiatry, University of Kentucky College of Medicine, 3470 Blazer Pkwy, Lexington, KY 40509-1810, United States.
Philip M WestgateDepartment of Biostatistics, University of Kentucky College of Public Health, 111 Washington Ave, Lexington, KY 40536, United States.
Joshua A LileDepartment of Behavioral Science, University of Kentucky College of Medicine, College of Medicine Office Building, Lexington, KY 40536-0086, United States; Department of Psychology, University of Kentucky College of Arts and Sciences, 106-B Kastle Hall, Lexington, KY 40506-0044, United States; Department of Psychiatry, University of Kentucky College of Medicine, 3470 Blazer Pkwy, Lexington, KY 40509-1810, United States. Electronic address: jalile2@email.uky.edu.

Funding

Kentucky Center for Clinical and Translational ScienceUL1TR001998 · NCATS · UNIVERSITY OF KENTUCKY · PI HARTMANN, KATHERINE E, KERN, PHILIP A · 2016 to 2025
$34.2M
Training and Pilot CoreP50DA005312 · NIDA · UNIVERSITY OF KENTUCKY · PI LYNAM, DONALD R · 1987 to 2016
$19.5M
Kentucky Center for Clinical and Translational ScienceUL1TR000117 · NCATS · UNIVERSITY OF KENTUCKY · PI KERN, PHILIP A · 2012 to 2015
$13.3M
Research Training in Drug Abuse BehaviorT32DA035200 · NIDA · UNIVERSITY OF KENTUCKY · PI CRAIG R RUSH, William Walton Stoops · 2013 to 2026
$4.4M
Human Laboratory Screening of Pregabalin and Tiagabine for Cannabis DependenceR01DA036550 · NIDA · UNIVERSITY OF KENTUCKY · PI LILE, JOSHUA ANTHONY · 2014 to 2019
$2.1M
GABA Drugs for Cannabis-Use Disorders: Initial Mechanistic Studies in HumansR01DA025605 · NIDA · UNIVERSITY OF KENTUCKY · PI LILE, JOSHUA ANTHONY · 2008 to 2011
$1.4M
A Pharmacological Analysis of Delta 9-THC in HumansK01DA018772 · NIDA · UNIVERSITY OF KENTUCKY · PI LILE, JOSHUA ANTHONY · 2005 to 2009
$729k
Medications Development for Cannabis-Use Disorders: Clinical StudiesK02DA031766 · NIDA · UNIVERSITY OF KENTUCKY · PI LILE, JOSHUA ANTHONY · 2011 to 2015
$487k
NCATS NIH HHS UL1 TR000117NCATS NIH HHS UL1 TR001998NIDA NIH HHS K01 DA018772NIDA NIH HHS K02 DA031766NIDA NIH HHS P50 DA005312NIDA NIH HHS R01 DA025605NIDA NIH HHS R01 DA036550NIDA NIH HHS T32 DA035200
6 · The paper itself

Abstract

Previous studies suggest that there are sex differences in endocannabinoid function and the response to exogenous cannabinoids, though data from clinical studies comparing acute cannabinoid effects in men and women under controlled laboratory conditions are limited. To further explore these potential differences, data from 30 cannabis users (N=18 M, 12 F) who completed previous Δ

Indexed as

Self-AssessmentSex CharacteristicsDiscrimination, PsychologicalDose-Response Relationship, DrugDouble-Blind MethodDronabinolFemaleHeart RateHumansMalePsychomotor PerformanceRetrospective StudiesYoung AdultDronabinolCannabisDrug-discriminationGenderMarijuanaSelf-report

Identifiers

PMID26780348
PMCPMC4947027

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.